715 related articles for article (PubMed ID: 3005417)
21. Differential ability of tumor-unique and cross-reactive antigen(s) on two murine hepatoma cell lines to induce Lyt-1+2- T cells responsible for in vivo protective immunity.
Shima J; Yoshioka T; Kosugi A; Ogata M; Fujiwara H; Hamaoka T; Ueda S; Kato S
Biken J; 1987 Mar; 30(1):1-8. PubMed ID: 2445335
[TBL] [Abstract][Full Text] [Related]
22. T cell-accessory cell interactions that initiate allospecific cytotoxic T lymphocyte responses: existence of both Ia-restricted and Ia-unrestricted cellular interaction pathways.
Singer A; Kruisbeek AM; Andrysiak PM
J Immunol; 1984 May; 132(5):2199-209. PubMed ID: 6201534
[TBL] [Abstract][Full Text] [Related]
23. Establishment of tumor-specific immunotherapy model utilizing vaccinia virus-reactive helper T cell activity.
Shimizu Y; Hasumi K; Masubuchi K; Okudaira Y
Eur J Immunol; 1988 Nov; 18(11):1773-8. PubMed ID: 2974424
[TBL] [Abstract][Full Text] [Related]
24. The role of I-region associated antigen (Ia)-bearing accessory cells in the generation of cytotoxic T cells in a subpopulation of thymocytes.
Okuno K; Kikuchi Y; Tsuchida T; Hamaoka T; Igarashi T; Kato R; Takatsu K
Jpn J Cancer Res; 1986 Jul; 77(7):711-21. PubMed ID: 3091558
[TBL] [Abstract][Full Text] [Related]
25. T cell responses induced by the parenteral injection of antigen-modified syngeneic cells. I. Induction, characterization, and regulation of antigen-specific T helper cells involved in delayed-type hypersensitivity responses.
Miller SD; Butler LD
J Immunol; 1983 Jul; 131(1):77-85. PubMed ID: 6190929
[TBL] [Abstract][Full Text] [Related]
26. Demonstration of intratumoral infiltration of tumor-specific Lyt-1+2- T cells mediating delayed-type hypersensitivity response and in vivo protective immunity.
Tomita S; Fujiwara H; Yamane Y; Sano S; Nakajima H; Izumi Y; Arai H; Kawanishi Y; Tsuchida T; Hamaoka T
Jpn J Cancer Res; 1986 Feb; 77(2):182-9. PubMed ID: 3082830
[TBL] [Abstract][Full Text] [Related]
27. Induction of antigen-specific antibody responses in primed and unprimed B cells. Functional heterogeneity among Th1 and Th2 T cell clones.
DeKruyff RH; Ju ST; Hunt AJ; Mosmann TR; Umetsu DT
J Immunol; 1989 Apr; 142(8):2575-82. PubMed ID: 2522962
[TBL] [Abstract][Full Text] [Related]
28. Heterogeneity of CD4+ T cells involved in anti-allo-class I H-2 immune responses. Functional discrimination between the major proliferating cells and helper cells assisting cytotoxic T cell responses.
Kitagawa S; Sato S; Azuma T; Shimizu J; Hamaoka T; Fujiwara H
J Immunol; 1991 Apr; 146(8):2513-21. PubMed ID: 1673140
[TBL] [Abstract][Full Text] [Related]
29. T-cell responses induced by the parenteral injection of antigen-modified syngeneic cells. II. Mechanisms, specificity, and cellular analysis of 2,4,6-trinitrophenol (TNP)-specific cytolytic response priming by intravenous versus subcutaneous injection with TNP-modified syngeneic cells.
Miller SD; Butler LD; Cleveland RP; Moorhead JW; Claman HN; Chiller JC
Cell Immunol; 1983 Dec; 82(2):378-93. PubMed ID: 6197193
[TBL] [Abstract][Full Text] [Related]
30. Killer-helper effect of L cells in the generation of anti-MM cytotoxic T lymphocytes: replacement by beta-interferon and mechanisms of action.
Ishikawa S; Tachibana T
Jpn J Cancer Res; 1986 Sep; 77(9):931-40. PubMed ID: 2945807
[TBL] [Abstract][Full Text] [Related]
31. Cognate interactions between helper T cells and B cells. I. Cloning and helper activity of a lymphokine-dependent helper T cell clone (Th-3).
Noelle RJ; McCann J
J Mol Cell Immunol; 1989; 4(3):161-73; discussion 173-5. PubMed ID: 2527511
[TBL] [Abstract][Full Text] [Related]
32. Epidermal cells as accessory cells in the generation of allo-reactive and hapten-specific cytotoxic T lymphocyte (CTL) responses.
Steiner G; Wolff K; Pehamberger H; Stingl G
J Immunol; 1985 Feb; 134(2):736-41. PubMed ID: 2578162
[TBL] [Abstract][Full Text] [Related]
33. The effect of cyclophosphamide on cytotoxic T-lymphocyte responses: inhibition of helper T-cell induction in vitro.
Varkila K; Hurme M
Immunology; 1983 Mar; 48(3):433-8. PubMed ID: 6219062
[TBL] [Abstract][Full Text] [Related]
34. Decline, in aging mice, of the anti-2,4,6-trinitrophenyl (TNP) cytotoxic T cell response attributable to loss of Lyt-2-, interleukin 2-producing helper cell function.
Miller RA; Stutman O
Eur J Immunol; 1981 Oct; 11(10):751-6. PubMed ID: 6975716
[TBL] [Abstract][Full Text] [Related]
35. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
[TBL] [Abstract][Full Text] [Related]
36. Defective thymic education of L3T4+ T helper cell function in graft-vs-host mice.
Fukuzawa M; Via CS; Shearer GM
J Immunol; 1988 Jul; 141(2):430-9. PubMed ID: 2968400
[TBL] [Abstract][Full Text] [Related]
37. Differential helper and effector responses of Lyt-2+ T cells to H-2Kb mutant (Kbm) determinants and the appearance of thymic influence on anti-Kbm CTL responsiveness.
Mizuochi T; Munitz TI; McCarthy SA; Andrysiak PM; Kung J; Gress RE; Singer A
J Immunol; 1986 Nov; 137(9):2740-7. PubMed ID: 2944960
[TBL] [Abstract][Full Text] [Related]
38. Induction of minor alloantigen-specific T cell subsets in vivo: recognition of processed antigen by helper but not by cytotoxic T cell precursors.
Czitrom AA; Gascoigne NR; Edwards S; Waterfield DJ
J Immunol; 1984 Jul; 133(1):33-9. PubMed ID: 6202785
[TBL] [Abstract][Full Text] [Related]
39. Enhanced induction of tumor-specific Lyt-1+2- T cell-mediated protective immunity by in vivo administration of interleukin 1.
Izumi Y; Tsuchida T; Okuno K; Fujiwara H; Hamaoka T
Jpn J Cancer Res; 1985 Sep; 76(9):863-70. PubMed ID: 3932286
[TBL] [Abstract][Full Text] [Related]
40. Immunoregulation by mouse T cell clones. III. Cloned H-Y-specific cytotoxic T cells secrete a soluble mediator(s) that inhibits cytotoxic responses by acting on both Lyt-2- and L3T4- lymphocytes.
Simon MM; Nerz G; Prester M; Moll H
Eur J Immunol; 1985 Aug; 15(8):773-83. PubMed ID: 2411568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
